UnknownPhase 3NCT01619462
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
Studying Pneumococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Papua New Guinea Institute of Medical Research
- Principal Investigator
- William S Pomat, PhDPapua New Guinea Institute of Medical Research
- Intervention
- Prevenar 13 and Synflorix(biological)
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2011 – 2016
Study locations (1)
- Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea
Collaborators
The University of Western Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01619462 on ClinicalTrials.govOther trials for Pneumococcal meningitis
Additional recruiting or active studies for the same condition.